Curie Therapeutics: Funding, Investors & Team (Oct 2026)
Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. Curie's radiopharmaceuticals are composed of rationally designed conjugates against carefully selected biological targets, to deliver alpha and beta-emitting radionuclide payloads.
Curie Therapeutics has raised $75.0M across 1 funding round on record, the most recent a Series A of $75.0M announced in Dec 2021.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Curie Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Curie Therapeutics Funding Rounds
Curie Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Curie Therapeutics Funding Compared to Other Health Care Startups
Curie Therapeutics' latest round of $75.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Curie Therapeutics in Health Care and Boston
Companies Similar to Curie Therapeutics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Curie Therapeutics Funding FAQs
What does Curie Therapeutics do?
Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. Curie's radiopharmaceuticals are composed of rationally designed conjugates against carefully selected biological targets, to deliver alpha and beta-emitting radionuclide payloads.
How much funding has Curie Therapeutics raised?
Curie Therapeutics has raised $75.0M across 1 round on record. The most recent is a Series A of $75.0M announced in Dec 2021.
When did Curie Therapeutics last raise funding?
Curie Therapeutics' most recent funding round on record is a Series A of $75.0M, announced in Dec 2021.
Who is the CEO of Curie Therapeutics?
Simon Read is listed as CEO at Curie Therapeutics.
Where is Curie Therapeutics headquartered?
Curie Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Curie Therapeutics have?
Curie Therapeutics is in the 11-50 employee band.
How does Curie Therapeutics' funding compare to other Health Care startups?
Curie Therapeutics' latest round of $75.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Curie Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Curie Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.